Summary

This study introduces a transfer learning method for automated acute leukemia classification, improving accuracy for acute lymphoblastic leukemia (ALL) by leveraging data from acute myeloid leukemia (AML). The approach enhances measurable residual disease (MRD) detection, particularly benefiting younger and older ALL patients.